Abstract
Bioassay-guided fractionation of the EtOAc-soluble extract of Pueraria lobata based on the inhibition of Aβ-induced toxicity in PC12 cells resulted in the isolation of four known active compounds, genistein (8), biochanin A (9), sissotrin (10), and puerol B (11). Of these, genistein (8) and biochanin A (9) exhibited potent neuroprotective effects with ED50 values of 33.7 and 27.8 μM, respectively. In addition, a new coumestan, 2-(α,α-dimethylallyl)coumestrol (1) was isolated and characterized, but proved to be inactive, as were additional seven known compounds. The structure of new compound 1 was determined using spectroscopic techniques.
Similar content being viewed by others
References
Arao, T., Kinjo, J., Nohara, T., and Isobe, R., Oleanene-type triterpene glycosides from Puerariae radix. IV. Six new saponins from Pueraria lobata. Chem. Pharm. Bull., 45, 362–366 (1997).
Baek, M. R., Choi, Y. H., Yoo, D. S., Kim, M. R., Choi, S. U., Hong, K. S., Kim, Y. S., Kim, Y.-K., Lee, K. R., and Ryu, S. Y., Anti-proliferative components in the roots extract from Pueraria thunbergiana. Korean J. Pharmacog., 40, 46–50 (2009).
Campbell, V. A. and Gowran, A., Alzheimer’s disease; taking the edge off with cannabinoids? Br. J. Pharmacol., 152, 655–662 (2007).
Hirakura, K., Morita, M., Nakajima, K., Sugama, K., Takagi, K., Niitsu, K., Ikeya, Y., Maruno, M., and Okada, M., Phenolic glucosides from the root of Pueraria lobata. Phytochemistry, 46, 921–928 (1997).
Hsieh, H.-M., Wua, W.-M., and Hu, M.-L., Soy isoflavones attenuate oxidative stress and improve parameters related to aging and Alzheimer’s disease in C57BL/6J mice treated with D-galactose. Food Chem. Toxicol., 47, 625–632 (2009).
Hou, Y., Yu, Y. B., Liu, G., and Luo, Y., A natural squamosamide derivative FLZ reduces amyloid-beta production by increasing non-amyloidogenic AbetaPP processing. J. Alzheimers Dis., 18, 153–165 (2009).
Kaneko, M., Nakata, H., Takada, F., Matsumura, M., Kitagawa, C., Sakashita, S., Nuno, M., and Saitoh, T., Isoflavones from the gall and wood of Wisteria brachybotrys. Phytochemistry, 27, 267–269 (1988).
Kang, B. H., Ecological flora of Korean medicinal plants, Geobook, Seoul, (2008).
Kinjo, J., Kurusawa, J., Baba, J., Takeshita, T., Yamasaki, M., and Nohara, T., Studies on the constituents of Pueraria lobata. III: Isoflavonoids and related compounds in the roots and the voluble stems. Chem. Pharm. Bull., 35, 4846–4850 (1987).
Lee, S. J., Baek, H. J., Lee, C. H., and Kim, H. P., Antiinflammatory activity of isoflavonoids from Pueraria radix and biochanin A derivatives. Arch. Pharm. Res., 17, 31–35 (1994).
Lewis, P., Kaltia, S., and Wähälä, K., The phase transfer catalysed synthesis of isoflavone-O-glucosides. J. Chem. Soc. Perkin Trans. I, 16, 2481–2484 (1998).
Nohara, T., Kinjo, J., Furusawa, J., Sakai, Y., Inoue, M., Shirataki, Y., Ishibashi, Y., Yokoe, I., and Komatsu, M., But-2-enolides from Pueraria lobata and revised structures of puerosides A, B and sophoroside A. Phytochemistry, 33, 1207–1210 (1993).
Overstreet, D. H., Kralic, J. E., Morrow, A. L., Ma, Z. Z., Zhang, Y. W., and Lee, D. Y., NPI-031G (puerarin) reduces anxiogenic effects of alcohol withdrawal or benzodiazepine inverse or 5-HT2C agonists. Pharmacol. Biochem. Behav., 75, 619–625 (2003).
Park, S.-Y., Kim, H.-S., Hong, S. S., Sul, D., Hwang, K. W., and Lee, D., The neuroprotective effects of traditional oriental herbal medicines against β-amyloid-induced toxicity. Pharm. Biol., 47, 976–981 (2009).
Zhang, H. Y., Liu, Y. H., Wang, H. Q., Xu, J. H., and Hu, H. T., Puerarin protects PC12 cells against beta-amyloidinduced cell injury. Cell Biol. Int., 32, 1230–1237 (2008).
Zhao, L., Chen, Q., and Diaz Brinton, R., Neuroprotective and neurotrophic efficacy of phytoestrogens in cultured hippocampal neurons. Exp. Biol. Med., 227, 509–519 (2002).
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Choi, Yh., Hong, S.S., Shin, Y.S. et al. Phenolic compounds from Pueraria lobata protect PC12 cells against Aβ-induced toxicity. Arch. Pharm. Res. 33, 1651–1654 (2010). https://doi.org/10.1007/s12272-010-1014-7
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12272-010-1014-7